Literature DB >> 7745744

Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus.

M Frese1, G Kochs, U Meier-Dieter, J Siebler, O Haller.   

Abstract

Thogoto and Dhori viruses are tick-borne orthomyxoviruses infecting humans and livestock in Africa, Asia, and Europe. Here, we show that human MxA protein is an efficient inhibitor of Thogoto virus but is inactive against Dhori virus. When expressed in the cytoplasm of stably transfected cell lines, MxA protein interfered with the accumulation of Thogoto viral RNA and proteins. Likewise, MxA(R645), a mutant MxA protein known to be active against influenza virus but inactive against vesicular stomatitis virus, was equally efficient in blocking Thogoto virus growth. Hence, a common antiviral mechanism that is distinct from the antiviral action against vesicular stomatitis virus may operate against both influenza virus and Thogoto virus. When moved to the nucleus with the help of a foreign nuclear transport signal, MxA(R645) remained active against Thogoto virus, indicating that a nuclear step of virus replication was inhibited. In contrast, Dhori virus was not affected by wild-type or mutant MxA protein, indicating substantial differences between these two tick-transmitted orthomyxoviruses. Human MxB protein had no antiviral activity against either virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745744      PMCID: PMC189115          DOI: 10.1128/JVI.69.6.3904-3909.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Nucleotide sequence of the tick-borne orthomyxo-like Dhori/India/1313/61 virus membrane protein gene.

Authors:  W C Clay; F J Fuller
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

2.  Complete nucleotide sequence of the tick-borne, orthomyxo-like Dhori/Indian/1313/61 virus nucleoprotein gene.

Authors:  F J Fuller; E Z Freedman-Faulstich; J A Barnes
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

Review 3.  Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus.

Authors:  P Staeheli; O Haller
Journal:  Interferon       Date:  1987

4.  Abortion in sheep caused by Thogoto virus.

Authors:  F G Davies; R K Soi; B N Wariru
Journal:  Vet Rec       Date:  1984 Dec 22-29       Impact factor: 2.695

5.  Arthropod-borne viral infections of man in Nigeria, 1964-1970.

Authors:  D L Moore; O R Causey; D E Carey; S Reddy; A R Cooke; F M Akinkugbe; T S David-West; G E Kemp
Journal:  Ann Trop Med Parasitol       Date:  1975-03

6.  The effect of virus-immune hosts on Thogoto virus infection of the tick, Rhipicephalus appendiculatus.

Authors:  L D Jones; P A Nuttall
Journal:  Virus Res       Date:  1989-10       Impact factor: 3.303

7.  No enhanced influenza virus resistance of murine and avian cells expressing cloned duck Mx protein.

Authors:  L Bazzigher; A Schwarz; P Staeheli
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

8.  Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus.

Authors:  T Zürcher; J Pavlovic; P Staeheli
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  Isolation of Dhori virus from Hyalomma marginatum ticks in Portugal.

Authors:  A R Filipe; J Casals
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

10.  Mechanism of human MxA protein action: variants with changed antiviral properties.

Authors:  T Zürcher; J Pavlovic; P Staeheli
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  48 in total

1.  A monomeric GTPase-negative MxA mutant with antiviral activity.

Authors:  C Janzen; G Kochs; O Haller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome.

Authors:  Kadir Turan; Masaki Mibayashi; Kenji Sugiyama; Shoko Saito; Akiko Numajiri; Kyosuke Nagata
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

3.  Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice.

Authors:  Andreas Pichlmair; Johanna Buse; Stephanie Jennings; Otto Haller; Georg Kochs; Peter Staeheli
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

4.  Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids.

Authors:  G Kochs; O Haller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes.

Authors:  F Weber; O Haller; G Kochs
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Bovine and water buffalo Mx2 genes: polymorphism and antiviral activity.

Authors:  H A E Babiker; Y Nakatsu; K Yamada; A Yoneda; A Takada; J Ueda; H Hata; T Watanabe
Journal:  Immunogenetics       Date:  2006-11-21       Impact factor: 2.846

Review 7.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

8.  The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer.

Authors:  Shanora Glymph; Sanjay Mandal; Ashley Evans Knowell; Fisseha Abebe; Jaideep Chaudhary
Journal:  Infect Genet Evol       Date:  2013-02-22       Impact factor: 3.342

9.  Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal.

Authors:  Bianca Schulte; Cindy Buffone; Silvana Opp; Francesca Di Nunzio; Daniel Augusto De Souza Aranha Vieira; Alberto Brandariz-Nuñez; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

10.  Inhibition of infectious pancreatic necrosis virus replication by atlantic salmon Mx1 protein.

Authors:  Rannveig Larsen; Torunn P Røkenes; Børre Robertsen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.